University of Pisa-ko ikertzaileekin lankidetzan egindako argitalpenak (14)

2022

  1. A first update on mapping the human genetic architecture of COVID-19

    Nature

  2. Whole-genome sequencing reveals host factors underlying critical COVID-19

    Nature, Vol. 607, Núm. 7917, pp. 97-103

2019

  1. Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2)

    Nature Genetics

  2. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

    Nature Genetics, Vol. 51, Núm. 3, pp. 414-430

  3. Transethnic meta-analysis of rare coding variants in PLCG2, ABI3, and TREM2 supports their general contribution to Alzheimer’s disease

    Translational Psychiatry, Vol. 9, Núm. 1

2015

  1. Convergent genetic and expression data implicate immunity in Alzheimer's disease

    Alzheimer's and Dementia, Vol. 11, Núm. 6, pp. 658-671

2014

  1. Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease

    PLoS ONE, Vol. 9, Núm. 6

2013

  1. Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease

    Molecular Psychiatry, Vol. 18, Núm. 4, pp. 461-470

  2. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

    Nature Genetics, Vol. 45, Núm. 12, pp. 1452-1458

2011

  1. APOE and Alzheimer disease: A major gene with semi-dominant inheritance

    Molecular Psychiatry, Vol. 16, Núm. 9, pp. 903-907

  2. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

    Nature Genetics, Vol. 43, Núm. 5, pp. 429-436

  3. Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations

    Neurobiology of Aging, Vol. 32, Núm. 4, pp. 756.e11-756.e15

2010

  1. The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: A meta-analysis study

    Journal of Alzheimer's Disease, Vol. 22, Núm. 1, pp. 247-255

2009

  1. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

    Nature Genetics, Vol. 41, Núm. 10, pp. 1094-1099